You just read:

Braeburn and Camurus Announce Initiation of a Phase 2 Study in Opioid Dependent Patients with Moderate to Severe Chronic Pain

News provided by

Braeburn Pharmaceuticals, Inc.; Camurus

Feb 22, 2016, 02:00 ET